WHO ICTRP trial
Investigation of the effect of pentoxifylline on the prevention of radio…
IRCT20161219031464N4 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20161219031464N4 |
|---|---|
| Public title | Investigation of the effect of pentoxifylline on the prevention of radio contrast nephropathy |
| Scientific title | Evaluation of the effect of oral pentoxifylline on prevention of radiocontrast nephropathy in patient that undergone angiographye |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Kidney disorders caused by contrast material following angiography. |
| Interventions | Intervention 1: Intervention group: In this group, they receive normal saline at a dose of one cc per kilogram of body weight and pentoxifylline (400 mg orally every 8 hours) for 12 hours before and 12 hours after angiography,. Intervention… |
| Registration date | Sep 8, 2020 |
| Target size | 192 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: